Triple-negative breast carcinoma (TNBC) is a biologically and clinically heterogeneous group of tumors defined by the absence of estrogen receptor (ER), progesterone receptor (PR), and HER2 expression [1,2,3]. This evidence concerns the gene PGR and triple-negative breast carcinoma.